Cargando…
Accurate prediction of response to endocrine therapy in breast cancer patients: current and future biomarkers
Approximately 70% of patients have breast cancers that are oestrogen receptor alpha positive (ER+) and are therefore candidates for endocrine treatment. Many of these patients relapse in the years during or following completion of adjuvant endocrine therapy. Thus, many ER+ cancers have primary resis...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5131493/ https://www.ncbi.nlm.nih.gov/pubmed/27903276 http://dx.doi.org/10.1186/s13058-016-0779-0 |